• FCS’ Gordan Leads Study That Shows Community Oncology Practices Limit Financial Toxicity

  December 5, 2025 5:38 am

• Citius Oncology Announces U.S. Commercial Launch of LYMPHIR™, a Novel Cancer Immunotherapy for Cutaneous T-Cell Lymphoma (CTCL)

  December 5, 2025 5:15 am

• Maha Zafar: Honored to Begin my Hematology/Oncology Journey at the Roswell Park Cancer Center

  December 5, 2025 4:31 am

• Lurbinectedin Contributes to Maintenance of Response in ES-SCLC

  December 5, 2025 4:05 am

• APPOS Boston 2026: Advanced Practice Providers Oncology Summit

  December 4, 2025 3:37 pm

• ESMO 2025 in review: A new era in oncology, from AI to next-gen therapeutics

  December 4, 2025 2:16 pm

• FCS’ Gordan Leads Study That Shows Community Oncology Practices Limit Financial Toxicity

  December 4, 2025 2:05 pm

• FCS’ Gordan Leads Study That Shows Community Oncology Practices Limit Financial Toxicity

  December 4, 2025 12:56 pm

• ESMO 2025 in review: A new era in oncology, from AI to next-gen therapeutics

  December 4, 2025 12:52 pm

• UnityPoint Health names new oncology leaders to expand cancer care across Iowa

  December 4, 2025 12:38 pm